Global Xerostomia Therapeutics Market Research Report 2023-2030: Analysis of Salivary Stimulants, Salivary Substitutes, and Dentifrices

DUBLIN, Jan. 8, 2024 /PRNewswire/ -- The "Xerostomia Therapeutics Market Size, Share & Trends Analysis Report By Type (OTC, Prescription), By Product (Salivary Stimulants, Salivary Substitutes, Dentifrices), By Region, And Segment Forecasts, 2023 - 2030" report has been added to ResearchAndMarkets.com's offering.

https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg

The global xerostomia therapeutics market size is expected to reach USD 2.70 billion by 2030, expanding at a CAGR of 3.8% from 2023 to 2030

Increase in favorable reimbursement policies for xerostomia products and growing awareness about associated diseases are the major factors contributing toward market growth.

In addition, increasing prevalence of xerostomia and associated diseases such as Sjogren's syndrome, diabetes, hypertension, and Parkinson's disease has a positive impact on the overall market. According to Colgate-Palmolive Company, 25 million people in the U.S. experience dry mouth. According to Sjogren Syndrome Foundation of America, around 4 million Americans are suffering from Sjogren's syndrome, an autoimmune disorder.

Growing initiatives for raising awareness about xerostomia and associated diseases are expected to drive growth. For instance, Sjogren Syndrome Foundation of America conducts awareness programs and supports patients suffering from the syndrome in the U.S. and Canada. In 2012, the foundation launched the "5-Year Breakthrough Goal" with an aim to reduce the time required to diagnose the condition to less than 2.5 years by 2017.

Furthermore, major players focus on acquiring emerging companies and conduct programs to raise awareness about dry mouth condition. For instance, Orajel, a brand of Church & Dwight Co., Inc. initiated a campaign with the help of iCrossing, a digital marketing agency to educate parents about the importance of oral care.

Xerostomia Therapeutics Market Report Highlights

    --  The global xerostomia therapeutics market size was estimated at USD 2.0
        billion in 2022 and is expected to grow with CAGR of 3.8% from 2023 to
        2030
    --  The OTC segment dominated the market due to factors such as ease in
        availability, affordability, and higher efficiency
    --  The dentifrices segment is expected to grow at the fastest CAGR over the
        forecast period.
    --  North America held the largest share in 2022 owing to factors such as
        increasing prevalence of diseases resulting in dry mouth and growing
        initiatives for raising awareness about xerostomia
    --  The Asia Pacific region is anticipated to witness lucrative growth over
        the next decade due to increasing awareness of the disease and growing
        healthcare expenditure
    --  Some of the key players such as GlaxoSmithKline plc; Church & Dwight
        Co., Inc.; and Colgate-Palmolive Company dominated the global xerostomia
        therapeutics market

Company Profiles

    --  Acacia Pharma
    --  Parnell Pharmaceuticals, Inc.
    --  Pfizer, Inc.
    --  GlaxoSmithKline plc
    --  Church & Dwight Co., Inc.
    --  Lupin
    --  Sun Pharmaceutical Industries, Ltd.
    --  Hikma Pharmaceuticals PLC
    --  Pendopharm
    --  OraCoat

Key Topics Covered:

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Research Methodology
1.3. Information Procurement
1.4. Information or Data Analysis
1.5. Market Formulation & Validation
1.6. Model Details
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives

Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Product outlook
2.2.2. Regional outlook
2.3. Competitive Insights

Chapter 3. Xerostomia Therapeutics Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Market Dynamics
3.3.1. Market driver analysis
3.3.2. Market restraint analysis
3.4. Xerostomia Therapeutics Market Analysis Tools
3.4.1. Industry analysis - Porter's
3.4.2. PESTEL analysis

Chapter 4. Xerostomia Therapeutics: Type Estimates & Trend Analysis
4.1. Xerostomia Therapeutics Market: Key Takeaways
4.2. Xerostomia Therapeutics Market: Movement & Market Share Analysis, 2022 & 2030
4.3. Over-the-counter (OTC)
4.4. Prescription

Chapter 5. Xerostomia Therapeutics: Product Estimates & Trend Analysis
5.1. Xerostomia Therapeutics Market: Key Takeaways
5.2. Xerostomia Therapeutics Market: Movement & Market Share Analysis, 2022 & 2030
5.3. Salivary Stimulants
5.3.1. Salivary stimulants market estimates and forecast 2018 to 2030 (USD million)
5.4. Salivary Substitutes
5.5. Dentifrices

Chapter 6. Xerostomia Therapeutics Market: Regional Estimates & Trend Analysis
6.1. Regional Outlook
6.2. Xerostomia Therapeutics System Market by Region: Key Marketplace Takeaway

Chapter 7. Competitive Landscape
7.1. Recent Developments & Impact Analysis, By Key Market Participants
7.2. Market Participant Categorization

For more information about this report visit https://www.researchandmarkets.com/r/xpl6r3

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg

View original content:https://www.prnewswire.com/news-releases/global-xerostomia-therapeutics-market-research-report-2023-2030-analysis-of-salivary-stimulants-salivary-substitutes-and-dentifrices-302028370.html

SOURCE Research and Markets